Home » Topics » Regulatory

Regulatory
RSS

FDA approves Velphoro to treat hyperphosphatemia in patients with CKD on dialysis

Nov. 28, 2013

FDA approves Nexavar for thyroid cancer

Nov. 25, 2013

Onoact 50 approved in Japan for new indication

Nov. 22, 2013

European approval of Kineret for CAPS

Nov. 21, 2013

European Commission approves Prilocaine Lidocaine Plethora for premature ejaculation

Nov. 19, 2013

FDA approves ibrutinib for mantle cell lymphoma

Nov. 14, 2013

Noven Pharmaceuticals launches Brisdelle in the U.S.

Nov. 6, 2013

FDA approves Gazyva for previously untreated chronic lymphocytic leukemia

Nov. 4, 2013

Zohydro ER approved by the FDA for pain

Oct. 28, 2013

FDA approves GE Healthcare's brain imaging drug for Alzheimer's disease and dementia

Oct. 28, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...